| Autor: |
Tsai, Chiaojung Jillian, Yang, Jonathan T, Shaverdian, Narek, Patel, Juber, Shepherd, Annemarie F, Eng, Juliana, Guttmann, David, Yeh, Randy, Gelblum, Daphna Y, Namakydoust, Azadeh, Preeshagul, Isabel, Modi, Shanu, Seidman, Andrew, Traina, Tiffany, Drullinsky, Pamela, Flynn, Jessica, Zhang, Zhigang, Rimner, Andreas, Gillespie, Erin F, Gomez, Daniel R, Lee, Nancy Y, Berger, Michael, Robson, Mark E, Reis-Filho, Jorge S, Riaz, Nadeem, Rudin, Charles M, Powell, Simon N, Berger, Michael, Bromberg, Jacqueline, Chen, Linda, Dang, Chau, Das, Jeeban P, Drullinsky, Pamela, Eng, Julianna, Flynn, Jessica, Gelblum, Daphna Y, Gillespie, Erin F, Girshman, Jeffrey, Gomez, Daniel R, Gucalp, Ayca, Guttmann, David, Hajj, Carla, Higginson, Daniel, Iqbal, Afsheen, Khan, Atif J, LaPlant, Quincey, Lee, Nancy Y, Mann, Justin M, Modi, Shanu, Namakydoust, Azadeh, Ng, Kenneth, Patel, Juber, Powell, Simon N, Preeshagul, Isabel, Reis-Filho, Jorge S, Reyngold, Marsha, Riaz, Nadeem, Rimner, Andreas, Robson, Mark E, Rudin, Charles M, Sanford, Rachel, Seidman, Andrew D, Shah, Ronak, Shaverdian, Narek, Shepherd, Annemarie F, Shin, Jacob Y, Sugarman, Steven, Traina, Tiffany A, Tsai, Chiaojung Jillian, Wu, Abraham J, Xu, Amy J, Yang, Jonathan T, Yeh, Randy, Zhang, Zhigang, Zhi, Wanqing |
| Zdroj: |
The Lancet; January 2024, Vol. 403 Issue: 10422 p171-182, 12p |
| Abstrakt: |
Most patients with metastatic cancer eventually develop resistance to systemic therapy, with some having limited disease progression (ie, oligoprogression). We aimed to assess whether stereotactic body radiotherapy (SBRT) targeting oligoprogressive sites could improve patient outcomes. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
